Form D · Biotechnology

Skylark Bio, Inc.

Cambridge, MA · CIK 0001942495

Offering snapshot reported Apr 19, 2024 · SEC filing

Reported sold
$40.9M
Offering amount: $40.9M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 8, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$20.4M$40.9MAug 16, 2022: $22,889,315.00Aug 16, 2022Aug 14, 2023: $22,889,315.00Aug 14, 2023Apr 19, 2024: $40,889,315.00Apr 19, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$22,889,315 → $40,889,315

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 19, 2024Amendment$40,889,315$18,000,000vs Aug 14, 20232SEC filing
Aug 14, 2023Amendment$22,889,315$0vs Aug 16, 20222SEC filing
Aug 16, 2022Initial$22,889,315No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-456066

Source: Form D, filed Apr 19, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jodi A. Cook Director, Executive
Giampiero De Luca Director
Steve Gillis Director
Will Mc Lean Executive
Nilay Thakar Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
325 Vassar Street 2 A
Cambridge, MA, 02139